Wellington Management Group
TEVA icon

Wellington Management Group’s Teva Pharmaceuticals TEVA Stock Holding History

Wellington Management Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$218M Buy
7,251,828
+466,099
+7% +$15M 0.04% 362
2025
Q4 		$212M Sell
6,785,729
-110,109
-2% -$2.71M 0.04% 378
2025
Q3 		$139M Buy
6,895,838
+6,878,304
+39,228% +$121M 0.02% 470
2025
Q2 		$294K Sell
17,534
-120,602
-87% -$1.95M ﹤0.01% 1880
2025
Q1 		$2.12M Sell
138,136
-47,776
-26% -$853K ﹤0.01% 1541
2024
Q4 		$4.1M Buy
185,912
+3,816
+2% +$69.4K ﹤0.01% 1397
2024
Q3 		$3.28M Sell
182,096
-4,111
-2% -$71.9K ﹤0.01% 1428
2024
Q2 		$3.03M Sell
186,207
-52,593
-22% -$810K ﹤0.01% 1426
2024
Q1 		$3.37M Sell
238,800
-15,860
-6% -$200K ﹤0.01% 1423
2023
Q4 		$2.66M Sell
254,660
-89,927
-26% -$840K ﹤0.01% 1431
2023
Q3 		$3.51M Buy
344,587
+102,261
+42% +$952K ﹤0.01% 1368
2023
Q2 		$1.82M Buy
242,326
+46,712
+24% +$379K ﹤0.01% 1496
2023
Q1 		$1.73M Buy
195,614
+176,286
+912% +$1.74M ﹤0.01% 1537
2022
Q4 		$176K Hold
19,328
– – ﹤0.01% 1948
2022
Q3 		$156K Sell
19,328
-1,013
-5% -$8.96K ﹤0.01% 1986
2022
Q2 		$153K Sell
20,341
-10,997
-35% -$95.8K ﹤0.01% 2023
2022
Q1 		$294K Hold
31,338
– – ﹤0.01% 2019
2021
Q4 		$251K Hold
31,338
– – ﹤0.01% 2108
2021
Q3 		$305K Buy
31,338
+9,218
+42% +$86.3K ﹤0.01% 2041
2021
Q2 		$219K Sell
22,120
-43,970
-67% -$465K ﹤0.01% 2079
2021
Q1 		$763K Buy
66,090
+6,648
+11% +$76.2K ﹤0.01% 1771
2020
Q4 		$574K Sell
59,442
-9,338
-14% -$89.5K ﹤0.01% 1688
2020
Q3 		$620K Buy
68,780
+48,299
+236% +$511K ﹤0.01% 1664
2020
Q2 		$252K Buy
20,481
+5,791
+39% +$65.5K ﹤0.01% 1777
2020
Q1 		$132K Sell
14,690
-77,682,058
-100% -$796M ﹤0.01% 1867
2019
Q4 		$761M Buy
77,696,748
+1,703,249
+2% +$15.2M 0.16% 146
2019
Q3 		$523M Buy
75,993,499
+13,059,673
+21% +$100M 0.12% 188
2019
Q2 		$581M Buy
62,933,826
+4,437,282
+8% +$53.5M 0.13% 176
2019
Q1 		$917M Buy
58,496,544
+13,419,158
+30% +$237M 0.21% 118
2018
Q4 		$695M Buy
45,077,386
+6,528,245
+17% +$134M 0.17% 139
2018
Q3 		$830M Buy
38,549,141
+8,485,434
+28% +$197M 0.17% 138
2018
Q2 		$731M Sell
30,063,707
-8,475,470
-22% -$173M 0.16% 150
2018
Q1 		$659M Sell
38,539,177
-9,132,162
-19% -$178M 0.15% 158
2017
Q4 		$903M Buy
47,671,339
+12,381,850
+35% +$186M 0.2% 122
2017
Q3 		$621M Buy
35,289,489
+10,928,705
+45% +$246M 0.14% 169
2017
Q2 		$809M Buy
24,360,784
+6,680,939
+38% +$207M 0.19% 128
2017
Q1 		$567M Buy
17,679,845
+5,806,427
+49% +$198M 0.14% 173
2016
Q4 		$430M Buy
11,873,418
+2,178,646
+22% +$87M 0.11% 191
2016
Q3 		$446M Buy
9,694,772
+693,495
+8% +$36.2M 0.11% 191
2016
Q2 		$452M Buy
9,001,277
+194,662
+2% +$10.4M 0.12% 184
2016
Q1 		$471M Buy
8,806,615
+2,624,236
+42% +$154M 0.12% 176
2015
Q4 		$406M Buy
6,182,379
+6,022,445
+3,766% +$372M 0.11% 189
2015
Q3 		$9.03M Sell
159,934
-3,743,478
-96% -$243M ﹤0.01% 1201
2015
Q2 		$231M Sell
3,903,412
-3,169,362
-45% -$196M 0.06% 295
2015
Q1 		$441M Sell
7,072,774
-3,271,429
-32% -$190M 0.11% 184
2014
Q4 		$595M Sell
10,344,203
-592,358
-5% -$33M 0.16% 136
2014
Q3 		$588M Sell
10,936,561
-3,092,581
-22% -$164M 0.16% 137
2014
Q2 		$735M Sell
14,029,142
-18,334,889
-57% -$937M 0.2% 111
2014
Q1 		$1.71B Sell
32,364,031
-12,935,262
-29% -$598M 0.47% 47
2013
Q4 		$1.82B Sell
45,299,293
-13,705,520
-23% -$540M 0.52% 39
2013
Q3 		$2.23B Sell
59,004,813
-2,235,005
-4% -$87.2M 0.7% 24
2013
Q2 		$2.4B Buy
+61,239,818
New +$2.38B 0.78% 20

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group's TEVA Position: Q1 2026 in Review

Wellington Management Group increased its Teva Pharmaceuticals (TEVA) stake by 6.9% in Q1 2026, buying an estimated $15M and bringing the position to 7,251,828 shares worth $218M. The position accounts for 0.04% of the portfolio, ranked #362.

Wellington Management Group first reported a position in TEVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.4B in Q2 2013. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Wellington Management Group held 7,251,828 shares of Teva Pharmaceuticals worth $218M as of Q1 2026.
  • Wellington Management Group bought 466,099 Teva Pharmaceuticals shares in Q1 2026, an estimated $15M.
  • Teva Pharmaceuticals made up 0.04% of Wellington Management Group's portfolio in Q1 2026, its #362 holding.
  • Wellington Management Group first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Wellington Management Group's Teva Pharmaceuticals position peaked at $2.4B in Q2 2013.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.